All lobbying filings

CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Lobbying for HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION · patient advocacy organization for individuals suffering from a rare disease

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Maryland · House · Senate · $10,000.00 income · posted Jan 13, 2026

Official filing document

Bills named in this filing 2

HR 4016
Department of Defense Appropriations Act, 2026
HR 5304
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

Lobbying activity 2

Defense

Hereditary Hemorrhagic Telanglectasia (HHT)

Health Issues

HR 4016/S 2572, FY26 Defense Appropriations Act, Peer Reviewed Medical Research Program designation for Hereditary Hemorrhagic Telangiectasia (HHT); HR 5304/S 2587, FY26 Labor HHS Education Appropriations Act, National HHT Center of Excellence Program

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.